References
1. Karti SS, Odabasi Z, Korten V, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerging infectious diseases. 2004;10(8):1379.
2. Leblebicioglu H, Ozaras R, Fletcher TE, Beeching NJ. Crimean-Congo haemorrhagic fever in travellers: A systematic review. Travel medicine and infectious disease. 2016;14(2):73-80.
3. Nasirian H. Crimean-Congo hemorrhagic fever (CCHF) seroprevalence: A systematic review and meta-analysis. Acta tropica.2019;196:102-120.
4. Akıncı E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector-Borne and Zoonotic Diseases.2013;13(7):429-437.
5. Demirtas E, Bakir M, Buyuktuna SA, et al. Comparison of the Predictive Performance of qSOFA, APACHE2 and SGS for evaluation of the disease prognosis of CCHF patients at the Emergency Department.Japanese Journal of Infectious Diseases. 2020:JJID. 2019.2507.
6. Mazza BF, Machado FR, Mazza DD, Hassmann V. Evaluation of blood transfusion effects on mixed venous oxygen saturation and lactate levels in patients with SIRS/sepsis. Clinics. 2005;60(4):311-316.
7. Goyal M, Pines JM, Drumheller BC, Gaieski DF. Point-of-care testing at triage decreases time to lactate level in septic patients. The Journal of emergency medicine. 2010;38(5):578-581.
8. Foushee JA, Hope NH, Grace EE. Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays. Journal of antimicrobial chemotherapy. 2012;67(11):2560-2569.
9. Swanepoel R, Gill D, Shepherd A, Leman P, Mynhardt J, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Reviews of infectious diseases. 1989;11(Supplement_4):S794-S800.
10. Ergönül Ö, Şeref C, Eren Ş, et al. Cytokine response in Crimean‐Congo hemorrhagic fever virus infection. Journal of medical virology. 2017;89(10):1707-1713.
11. Kilinc C, Gückan R, Capraz M, et al. Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever. Journal of vector borne diseases. 2016;53(2):162.
12. Burt FJ, Swanepoel R, Shieh W-J, Smith JF. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Archives of pathology & laboratory medicine. 1997;121(8):839.
13. Kerget F, Özkurt Z, Öztürk N, Yilmaz S. The relationship with clinical course and prognosis of serum endothelin-1, angiopoietin-2, and tie-2 levels in Crimean-Congo hemorrhagic fever. Turkish journal of medical sciences. 2019;49(4):1192-1197.
14. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of IL-6, IL-10, and TNF-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis.
15. Ergönül Ö. Crimean-Congo haemorrhagic fever. The Lancet infectious diseases. 2006;6(4):203-214.
16. Kerget F, Demirdöğen ŞO, Kerget B. Case Report: A Rare Case of Crimean–Congo Hemorrhagic Fever Associated with Epididymo-Orchitis.The American Journal of Tropical Medicine and Hygiene.2021:tpmd201143.
17. Luft D, Deichsel G, Schmulling R-M, Stein W, Eggstein M. Definition of clinically relevant lactic acidosis in patients with internal diseases. American journal of clinical pathology.1983;80(4):484-489.
18. Kruse O, Grunnet N, Barfod C. Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospital: a systematic review. Scandinavian journal of trauma, resuscitation and emergency medicine. 2011;19(1):1-12.
19. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clinical infectious diseases. 2004;39(2):206-217.
20. Gul S, Ozturk DB, Kisa U, Kacmaz B, Yesilyurt M. Procalcitonin levels and their predictive effect on mortality in Crimean-Congo Hemorrhagic Fever Patients. Japanese journal of infectious diseases. 2015:JJID. 2014.2485.